A Study of Combination Therapies With or Without Pembrolizumab (MK-3475) and/or Chemotherapy in Participants With Advanced Esophageal Cancer (MK-3475-06A)
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Jacobio Pharmaceuticals Co., Ltd.
Ludwig Institute for Cancer Research
Sunshine Lake Pharma Co., Ltd.
Federation Francophone de Cancerologie Digestive
Swiss Cancer Institute
UNC Lineberger Comprehensive Cancer Center